| 000 | 01871 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517231916.0 | ||
| 264 | 0 | _c20200319 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1748-1716 | ||
| 024 | 7 |
_a10.1111/apha.13168 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVasconez, Andrea E | |
| 245 | 0 | 0 |
_aThe histone demethylase Jarid1b mediates angiotensin II-induced endothelial dysfunction by controlling the 3'UTR of soluble epoxide hydrolase. _h[electronic resource] |
| 260 |
_bActa physiologica (Oxford, England) _c01 2019 |
||
| 300 |
_ae13168 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a3' Untranslated Regions |
| 650 | 0 | 4 |
_aAcetylcholine _xpharmacology |
| 650 | 0 | 4 |
_aAngiotensin II _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAorta |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xmetabolism |
| 650 | 0 | 4 |
_aEpoxide Hydrolases _xgenetics |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aJumonji Domain-Containing Histone Demethylases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aNitroso Compounds _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aJanetzko, Patrick | |
| 700 | 1 | _aOo, James A | |
| 700 | 1 | _aPflüger-Müller, Beatrice | |
| 700 | 1 | _aRatiu, Corina | |
| 700 | 1 | _aGu, Lunda | |
| 700 | 1 | _aHelin, Kristian | |
| 700 | 1 | _aGeisslinger, Gerd | |
| 700 | 1 | _aFleming, Ingrid | |
| 700 | 1 | _aSchröder, Katrin | |
| 700 | 1 | _aFork, Christian | |
| 700 | 1 | _aBrandes, Ralf P | |
| 700 | 1 | _aLeisegang, Matthias S | |
| 773 | 0 |
_tActa physiologica (Oxford, England) _gvol. 225 _gno. 1 _gp. e13168 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apha.13168 _zAvailable from publisher's website |
| 999 |
_c28699534 _d28699534 |
||